Home > Qtrly Results > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
Quarterly Results Analysis [Mar2026]

SUN PHARMA ADVANCED RESEARCH COMPANY is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Quarterly Results

Consolidated Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
Audited
Jun2024
UnAudited
Revenues ₹1,853 Cr ₹8 Cr ₹8 Cr ₹10 Cr ₹27 Cr ₹15 Cr ₹13 Cr ₹17 Cr
Expenses ₹80 Cr ₹65 Cr ₹74 Cr ₹62 Cr ₹80 Cr ₹89 Cr ₹116 Cr ₹110 Cr
Operating Income ₹1,773 Cr ₹-57 Cr ₹-66 Cr ₹-52 Cr ₹-53 Cr ₹-74 Cr ₹-103 Cr ₹-93 Cr
Other Income ₹2 Cr ₹0 Cr ₹0 Cr ₹9 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹2 Cr
Interest ₹12 Cr ₹9 Cr ₹8 Cr ₹6 Cr ₹5 Cr ₹3 Cr ₹1 Cr ₹1 Cr
Depreciation ₹2 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr
Profit Before Tax ₹1,761 Cr ₹-80 Cr ₹-76 Cr ₹-52 Cr ₹-61 Cr ₹-79 Cr ₹-107 Cr ₹-96 Cr
Profit After Tax ₹1,761 Cr ₹-80 Cr ₹-76 Cr ₹-52 Cr ₹-60 Cr ₹-80 Cr ₹-107 Cr ₹-96 Cr
EPS ₹54.28 ₹-2.48 ₹-2.34 ₹-1.60 ₹-1.84 ₹-2.45 ₹-3.31 ₹-2.96
Industry Peers & Returns1W1M1Y
SUN PHARMA ADVANCED RESEARCH COMPANY 9.7% 32.4% 23.3%
SAGILITY 3.8% -6% 1%
SYNGENE INTERNATIONAL 2.1% -1.1% -30.6%
PRIME FOCUS -4.1% -13.4% 94.3%
INTERNATIONAL GEMOLOGICAL INSTITUTE 0.3% 11.9% -12%
INDEGENE -0.5% -1.9% -13%
NESCO 0.4% -12.6% 15.1%
LATENT VIEW ANALYTICS 0.1% 1.3% -30.3%
CMS INFO SYSTEMS -0.8% -0.1% -40.5%

SUN PHARMA ADVANCED RESEARCH COMPANY Quarterly Revenues

Revenues
Q-o-Q

21,831.60 %

Y-o-Y

6,715.81 %

Quarters Revenues % Change
Mar2026 ₹1,853 Cr
21,831.60
Dec2025 ₹8 Cr
7.51
Sep2025 ₹8 Cr
-18.46
Jun2025 ₹10 Cr
-64.55
Mar2025 ₹27 Cr
82.36
Dec2024 ₹15 Cr
15.94
Sep2024 ₹13 Cr
-23.50
Jun2024 ₹17 Cr -

SUN PHARMA ADVANCED RESEARCH COMPANY Quarterly Operating Profit

Operating Profit
Q-o-Q

Positive

Y-o-Y

Positive

Quarters Operating Profit % Change
Mar2026 ₹1,773 Cr
Positive
Dec2025 ₹-57 Cr
Negative
Sep2025 ₹-66 Cr
Negative
Jun2025 ₹-52 Cr
Negative
Mar2025 ₹-53 Cr
Negative
Dec2024 ₹-74 Cr
Negative
Sep2024 ₹-103 Cr
Negative
Jun2024 ₹-93 Cr -
Operating Margins
Q-o-Q

Positive

Y-o-Y

Positive

Quarters Operating Margin% % Change
Mar2026 95.68%
Positive
Dec2025 -670.3%
Negative
Sep2025 -836.13%
Negative
Jun2025 -540.25%
Negative
Mar2025 -195.59%
Negative
Dec2024 -494.23%
Negative
Sep2024 -800.23%
Negative
Jun2024 -555.38% -

SUN PHARMA ADVANCED RESEARCH COMPANY Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Positive

Y-o-Y

Positive

Quarters Profit After Tax % Change
Mar2026 ₹1,761 Cr
Positive
Dec2025 ₹-80 Cr
Negative
Sep2025 ₹-76 Cr
Negative
Jun2025 ₹-52 Cr
Negative
Mar2025 ₹-60 Cr
Negative
Dec2024 ₹-80 Cr
Negative
Sep2024 ₹-107 Cr
Negative
Jun2024 ₹-96 Cr -
PAT Margins
Q-o-Q

Positive

Y-o-Y

Positive

Quarters PAT Margin(%) % Change
Mar2026 95.04 %
Positive
Dec2025 -951.72 %
Negative
Sep2025 -965.01 %
Negative
Jun2025 -538.07 %
Negative
Mar2025 -219.82 %
Negative
Dec2024 -533.27 %
Negative
Sep2024 -834.6 %
Negative
Jun2024 -570.49 % -

SUN PHARMA ADVANCED RESEARCH COMPANY Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Positive

Y-o-Y

Positive

Quarters EPS % Change
Mar2026 ₹54.28
Positive
Dec2025 ₹-2.48
Negative
Sep2025 ₹-2.34
Negative
Jun2025 ₹-1.6
Negative
Mar2025 ₹-1.84
Negative
Dec2024 ₹-2.45
Negative
Sep2024 ₹-3.31
Negative
Jun2024 ₹-2.96 -

You may also like the below Video Courses